Search Result

Results for "

5-HT6R

" in MedChemExpress (MCE) Product Catalog:

By Targets:	5-HT Receptor (19) CDK (1) Cholinesterase (ChE) (1) Dopamine Receptor (1) HDAC (1) Histamine Receptor (1) Monoamine Oxidase (5) mTOR (1)
By Research Areas:	Cancer (2) Cardiovascular Disease (1) Neurological Disease (17)
Click Chemistry:	Alkynes (1)

Inhibitors & Agonists

Click Chemistry

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-109036

Landipirdine RO5025181; SYN120	5-HT Receptor	Neurological Disease
Landipirdine is a selective antagonist of *5-HT₆R*. Landipirdine has great effect on the hERG pharmacophore .

HY-156017

5-HT6R antagonist 1	5-HT Receptor	Cardiovascular Disease Neurological Disease
5-HT6R antagonist 1 (Comopund 8) is a *5-HT6R* antagonist (K_i: 5 nM). 5-HT6R antagonist 1 inhibits platelet aggregation. 5-HT6R antagonist 1 has excellent metabolic stability. 5-HT6R antagonist 1 reverses MK-801 (HY-15084B)-induced memory impairments in rats. 5-HT6R antagonist 1 can be used for Alzheimer's disease (AD) research .

HY-173043

5-HT6R antagonist 6	5-HT Receptor	Cancer
5-HT6R antagonist 6 exhibits high affinity and selectivity for *5-HT₆R* , with a K_i value of 42 nM. 5-HT6R antagonist 6 shows weak antiproliferative activity against tumor cells and low toxicity to normal cells. 5-HT6R antagonist 6 can be used in the study of cancer .

HY-162682

5-HT6R antagonist 4	5-HT Receptor	Neurological Disease
5-HT6R antagonist 4 (compound 30) is a neutral antagonist of *5-HT6R, with the K_i* of 1 nM .

HY-163150

5-HT6R antagonist 3	5-HT Receptor	Neurological Disease
5-HT6R antagonist 3 (compound 15) is a potent, selective and brain-penetrant *5-HT6R* antagonist with K_i values of 14 nM, 3533 nM, 35 nM, 1449 nM for 5-HT6, 5-HT1A, 5-HT2A, 5-HT7, respectively. 5-HT6R antagonist 3 shows anxiolytic-like and properties neuroprotective and procognitive-like effects. 5-HT6R antagonist 3 has the potential for the research of Alzheimer’s Disease .

HY-155316

5-HT6R antagonist 2	5-HT Receptor	Others
5-HT6R antagonist 2 (compound 29) is a 5-HT6 receptor antagonist .

HY-146677

5-HT6R/MAO-B modulator 1	5-HT Receptor Monoamine Oxidase	Neurological Disease
5-HT6R/MAO-B modulator 1 (compound 48) is an antagonist of *5-HT₆R* at Gs signaling and an irreversible MAO-B inhibitor. 5-HT6R/MAO-B modulator 1 exhibits glioprotective properties. 5-HT6R/MAO-B modulator 1 can reverse Scopolamine-induced memory deficits . 5-HT6R/MAO-B modulator 1 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

HY-173044

*5-HT1AR/5-HT6R* ligand-1**	5-HT Receptor Dopamine Receptor	Neurological Disease
5-HT1AR/5-HT6R ligand-1 (Compound PP13) is the ligand for 5-HT receptor that exhibits good affinity to 5-HT1AR, 5-HT6R and 5-HT7R (K_i of 19, 69 and 198 nM, respectively), thereby inhibiting the cAMP production in HEK293 cell with EC₅₀ of 1535, 488 and 53 nM, respectively. 5-HT1AR/5-HT6R ligand-1 exhibits anti-proliferative activity against a variety of cancer cells (IC₅₀ for 1321N1, U87MG, MCF7, and AsPC-1 is 9.6, 13.6, 19.3 and 14.6 μM, respectively). 5-HT1AR/5-HT6R ligand-1 also exhibits antagonist activity for dopamine receptor D2R with K_i of 1903 nM .

HY-19668A

SGS518 oxalate	5-HT Receptor	Neurological Disease
SGS518 oxalate is a selective *5-HT₆R* antagonist. SGS518 oxalate can be used for the research of cognitive impairments such as amnesia, anxiety and depression, and it is effective in protecting mouse retina at high doses ^[1]

HY-173045

*5-HT5AR/5-HT6R* ligand-1**	5-HT Receptor	Cancer
5-HT5AR/5-HT6R ligand-1 (Compound PP10) is a ligand for serotonin receptors, showing high affinity for 5-HT_5A and 5-HT₆ receptors, with K_i values of 59 nM and 96 nM, respectively. 5-HT5AR/5-HT6R ligand-1 exhibits certain antiproliferative activity against tumor cells and can be used in the study of cancer .

HY-101924

AVN-492	5-HT Receptor	Neurological Disease
AVN-492 is a very specific and highly-selective antagonist with picomolar affinity to *5-HT6R* (K_i=91 pM).

HY-172679

PUC-55	5-HT Receptor	Neurological Disease
PUC-55 is a *5-HT₆R* antagonist with a K_i of 37.5 nM that induces neuronal autophagy by inhibiting the mTOR pathway. It holds potential for research in the field of neurological disorders .

HY-109036A

(S)-Landipirdine (S)-RO5025181; (S)-SYN120	Others	Neurological Disease
(S)-Landipirdine ((S)-RO5025181), a selective and potent 5-HT6R antagonist, significantly impacts the hERG pharmacophore and serves as a valuable tool for investigating neurological disorders, particularly within the context of Alzheimer's disease.

HY-103130

EMD386088	5-HT Receptor	Neurological Disease
EMD386088 is a potent serotonin 6 receptor (5-HT6R) agonist. EMD386088 regulates the activity of ERK1/2. EMD386088 has the potential for the research of alzheimer's disease (AD) and schizophrenia .

HY-143329

MAO-B-IN-3	Monoamine Oxidase 5-HT Receptor	Neurological Disease
MAO-B-IN-3 is a reversible and selective MAO-B inhibitor (IC₅₀=96 nM). MAO-B-IN-3 also binds to 5-HT₆R with K_i value of 696 nM. MAO-B-IN-3 can be used for research of in Alzheimer's disease .

HY-170908

Pellotine	5-HT Receptor	Neurological Disease
Pellotine is an alkaloid that can be isolated from Lophophora. Pellotine is the inverse agonist for 5-HT7 receptor with an EC₅₀ of 291 nM. Pellotine exhibits good affinity to 5-HT1DR and *5-HT6R* with K_i of 117 nM and 170 nM. Pellotine reduces intracellular cAMP levels, thereby reducing neuronal excitability and neurotransmitter release .

HY-168333

5-HT6 inverse agonist 1	5-HT Receptor mTOR CDK	Neurological Disease
5-HT6 inverse agonist 1 (Compound 33) is an antagonist for 5-HT6 receptor with a K_i of 23 nM and a K_b of 6.62 nM. 5-HT6 inverse agonist 1 inhibits the 5-HT6R mediated Cdk5 and mTOR signaling pathway. 5-HT6 inverse agonist 1 reduces tactile hypersensitivity in spinal nerve ligation (SNL)-induced rat model .

HY-169156

HDAC6-IN-49	HDAC Monoamine Oxidase Cholinesterase (ChE) Histamine Receptor 5-HT Receptor	Neurological Disease
HDAC6-IN-49 (Compound 3) is an inhibitor for HDAC with IC₅₀ of 0.012 and 0.735 μM for HDAC6 and HDAC1. HDAC6-IN-49 also exhibits inhibitory activities against MAO-B, cholinesterase (ChE), histamine receptor (H3R) and serotonin 6 receptor (5-HT6R). HDAC6-IN-49 exhibits neuroprotective efficacy on SH-SY5Y cell. HDAC6-IN-49 improves cognitive function and locomotor ability in Drosophila Parkinson's disease models and in C. elegans Alzheimer's disease models .

HY-155330

PZ-1922	5-HT Receptor Monoamine Oxidase	Neurological Disease
PZ-1922 (Compound 16) is a BBB-penetrable *5-HT6R/5-HT3R* antagonist (K_i: 17 nM, 0.45 nM for 5-HT6R/5-HT3R respectively). PZ-1922 reversibly inhibits MAO-B (pIC₅₀: 8.93). PZ-1922 reverses Scopolamine (SCOP) (HY-N0296) induced memory deficits in the novel object recognition (NOR) test in rats. PZ-1922 prevents Aβ-induced memory decline in the T-maze test .

HY-155330A

PZ-1922 free base	5-HT Receptor Monoamine Oxidase	Neurological Disease
PZ-1922 free base is a BBB-penetrable *5-HT6R/5-HT3R* antagonist (K_i: 17 nM, 0.45 nM for 5-HT6R/5-HT3R respectively). PZ-1922 free base reversibly inhibits MAO-B (pIC₅₀: 8.93). PZ-1922 free base reverses Scopolamine (SCOP) (HY-N0296) induced memory deficits in the novel object recognition (NOR) test in rats. PZ-1922 free base prevents Aβ-induced memory decline in the T-maze test .

Cat. No.	Product Name		Classification

HY-146677

5-HT6R/MAO-B modulator 1		Alkynes
5-HT6R/MAO-B modulator 1 (compound 48) is an antagonist of *5-HT₆R* at Gs signaling and an irreversible MAO-B inhibitor. 5-HT6R/MAO-B modulator 1 exhibits glioprotective properties. 5-HT6R/MAO-B modulator 1 can reverse Scopolamine-induced memory deficits . 5-HT6R/MAO-B modulator 1 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Name
Email *

	Sorry, but the email address you supplied was invalid.